Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] gained 31.77% on the last trading session, reaching $2.53 price per share at the time.
Ironwood Pharmaceuticals Inc represents 162.68 million in outstanding shares, while the company has a total market value of $410.95 million with the latest information. IRWD stock price has been found in the range of $2.31 to $2.97.
If compared to the average trading volume of 1.38M shares, IRWD reached a trading volume of 20129143 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Ironwood Pharmaceuticals Inc [IRWD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IRWD shares is $1.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IRWD stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Ironwood Pharmaceuticals Inc shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on April 15, 2025. The new note on the price target was released on April 15, 2025, representing the official price target for Ironwood Pharmaceuticals Inc stock.
Price to Free Cash Flow for IRWD in the course of the last twelve months was 6.07 with Quick ratio for the last quarter at 1.13.
Trading performance analysis for IRWD stock
Ironwood Pharmaceuticals Inc [IRWD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 36.02. With this latest performance, IRWD shares gained by 59.62% in over the last four-week period, additionally plugging by 244.78% over the last 6 months – not to mention a drop of -42.89% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IRWD stock in for the last two-week period is set at 74.93, with the RSI for the last a single of trading hit 0.2800, and the three-weeks RSI is set at 0.2100 for Ironwood Pharmaceuticals Inc [IRWD]. The present Moving Average for the last 50 days of trading for this stock 1.5100, while it was recorded at 2.0900 for the last single week of trading, and 1.2300 for the last 200 days.
Ironwood Pharmaceuticals Inc [IRWD]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Ironwood Pharmaceuticals Inc [IRWD] shares currently have an operating margin of 42.92% and a Gross Margin at 99.44%. Ironwood Pharmaceuticals Inc’s Net Margin is presently recorded at 8.70%.
Ironwood Pharmaceuticals Inc (IRWD) Capital Structure & Debt Analysis
Ironwood Pharmaceuticals Inc (IRWD) Efficiency & Liquidity Metrics
Ironwood Pharmaceuticals Inc (IRWD) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Ironwood Pharmaceuticals Inc. (IRWD) effectively leverages its workforce, generating an average of $116521.74 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.13% and a Quick Ratio of 1.13%, indicating strong ability to cover short-term liabilities.
Ironwood Pharmaceuticals Inc [IRWD]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Ironwood Pharmaceuticals Inc posted 0.02/share EPS, while the average EPS was predicted by analysts to be reported at 0.08/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.06. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IRWD.
An analysis of Institutional ownership at Ironwood Pharmaceuticals Inc [IRWD]
There are presently around $95.00%, or 97.60%% of IRWD stock, in the hands of institutional investors. The top three institutional holders of IRWD stocks are: BLACKROCK INC. with ownership of 22.88 million shares, which is approximately 14.3868%. VANGUARD GROUP INC, holding 21.56 million shares of the stock with an approximate value of $$140.59 million in IRWD stocks shares; and VANGUARD GROUP INC, currently with $$106.86 million in IRWD stock with ownership which is approximately 10.3073%.
